carbamazepine has been researched along with risperidone in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (9.59) | 18.2507 |
2000's | 36 (49.32) | 29.6817 |
2010's | 24 (32.88) | 24.3611 |
2020's | 6 (8.22) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Sen, S; Sinha, N | 1 |
Doran, AC; Mancuso, JY; Osgood, SM; Shaffer, CL | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Centorrino, F; Froeschl, M; Hegarty, JI; Tohen, M; Zarate, CA; Zarate, SB | 1 |
Keck, PE; McElroy, SL; Strakowski, SM | 1 |
Baldassano, CF; Ghaemi, SN; Sachs, GS; Truman, CJ | 1 |
Bork, J; de Leon, J | 1 |
Yong, JN | 1 |
Chang, WH; Lane, HY | 1 |
Kane, JM | 1 |
Alfaro, CL; Lenane, M; Nicolson, R; Rapoport, JL | 1 |
Avenoso, A; Facciolà, G; Giacobello, T; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E | 1 |
Nemeroff, CB | 1 |
Avenoso, A; Perucca, E; Scordo, MG; Spina, E | 1 |
de Vries, R; Furukori, H; Kaneko, S; Kondo, T; Mihara, K; Ono, S; Suzuki, A; Yasui-Furukori, N | 1 |
Danileviciūte, V | 1 |
Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
Hume, JH; Kowatch, RA; Kromelis, M; Sethuraman, G; Weinberg, WA | 1 |
Binder, C; Connolly, M; Kusumakar, V; Leblanc, J; Riccardelli, R; Yatham, LN | 1 |
Azzoni, A; Raja, M | 1 |
Dittmann, S; Grunze, H | 1 |
Dietrich, DE; Emrich, HM; Heveling, T | 1 |
Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S | 1 |
Cacciola, M; D'Arrigo, C; La Torre, D; Migliardi, G; Pacetti, M; Rosaria Muscatello, M; Spina, E; Zoccali, R | 1 |
Duggal, HS; Mendhekar, DN | 1 |
Danielyan, A; Kowatch, RA | 1 |
Mehta, R; Mendhekar, DN | 1 |
Cipriani, A; Geddes, JR; Rendell, JM | 1 |
Atagun, I; Kaya, MC; Kurt, E; Oral, ET; Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
Burke, RS; Parker, JD; Reeves, RR | 1 |
Deb, S; Unwin, GL | 1 |
Preskorn, SH | 1 |
Kessler, H; Kraft, S | 1 |
Shen, YC | 1 |
Arvilommi, P; Isometsä, E; Leppämäki, S; Mantere, O; Suominen, K; Valtonen, HM | 1 |
Leckband, SG; Meyer, JM; Strack, DK | 1 |
de Leon, J; Diaz, FJ; Spina, E | 1 |
Schweitzer, I | 1 |
Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F | 1 |
Baumann, P; Greil, W; Grohmann, R; Häberle, A; Schuhmann, T | 1 |
Ersoz Alan, B; Unal, D | 1 |
Davis, MC; Kruse, JL | 1 |
Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S | 1 |
Gründer, G; Haen, E; Hiemke, C; Lammertz, SE; Paulzen, M; Schoretsanitis, G; Schruers, KR; Stegmann, B | 1 |
Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU | 1 |
Fuchs, PA; Miller, L; Schiff, M | 1 |
Agoub, M; Alami, KM; Attouche, N; Charra, B; Fadili, A | 1 |
Rojo-Moreno, J; Rojo-Valdemoro, C; Santolaya-Ochando, F | 1 |
Dhindsa, RS; Goldstein, DB; Krizay, DK; Vasavda, C; Zoghbi, AW | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
de Leon, J | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
Nabekura, T; Uwai, Y | 1 |
Masís-Mora, M; Méndez-Rivera, M; Montiel-Mora, JR; Ramírez-Morales, D; Rodríguez-Rodríguez, CE | 1 |
13 review(s) available for carbamazepine and risperidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New developments in the pharmacologic treatment of schizoaffective disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Clinical Trials as Topic; Clozapine; Drug Therapy, Combination; Humans; Psychotic Disorders; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Treatment Outcome; Valproic Acid | 1996 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroconvulsive Therapy; Electromagnetic Phenomena; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2000 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
[Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
Topics: Acute Disease; Algorithms; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Humans; Isotopes; Lamotrigine; Lithium; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazines; Valproic Acid | 2003 |
Management options for bipolar disorder in children and adolescents.
Topics: Adolescent; Benzodiazepines; Bipolar Disorder; Carbamazepine; Child; Clozapine; Dibenzothiazepines; Humans; Lithium; Olanzapine; Quetiapine Fumarate; Risperidone; Valproic Acid | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature].
Topics: Adult; Antipsychotic Agents; Brain; Carbamazepine; Chromosome Deletion; Citalopram; Compulsive Behavior; Craniofacial Abnormalities; Drug Therapy, Combination; Facies; Female; Gigantism; Hallucinations; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Learning Disabilities; Neurocognitive Disorders; Neuropsychological Tests; Nuclear Proteins; Risperidone; Selective Serotonin Reuptake Inhibitors; Syndrome | 2008 |
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Oxcarbazepine; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tranquilizing Agents; Valproic Acid | 2018 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
4 trial(s) available for carbamazepine and risperidone
Article | Year |
---|---|
Risperidone in the treatment of mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium Carbonate; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 1996 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Carbamazepine; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Lithium; Male; Methylphenidate; Prospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2003 |
Risperidone in acute and continuation treatment of mania.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium Compounds; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Time Factors; Valproic Acid | 2003 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid | 2004 |
56 other study(ies) available for carbamazepine and risperidone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dogs; Isoxazoles; Male; Paliperidone Palmitate; Primates; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Thiophenes | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Acute treatment of bipolar disorder with adjunctive risperidone in outpatients.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Treatment Outcome; Valproic Acid | 1997 |
Risperidone and cytochrome P450 3A.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Male; Oxidoreductases, N-Demethylating; Risperidone; Schizophrenia | 1997 |
Nefazodone and neurotoxicity.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Risperidone; Triazoles | 1997 |
Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
Topics: Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Humans; Oxidoreductases, N-Demethylating; Risperidone | 1998 |
Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Risperidone; Schizophrenia | 2000 |
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Risperidone; Valproic Acid | 2000 |
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Chronic Disease; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Therapy, Combination; Humans; Male; Risperidone; Schizophrenia | 2001 |
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes.
Topics: Adult; Carbamazepine; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Genotype; Humans; Male; Middle Aged; Risperidone; Schizophrenia; Statistics, Nonparametric | 2002 |
Oxcarbazepine, risperidone and atenolol overdose with benign outcome.
Topics: Adrenergic beta-Antagonists; Adult; Alcoholism; Anticonvulsants; Antipsychotic Agents; Atenolol; Bipolar Disorder; Carbamazepine; Cocaine-Related Disorders; Drug Overdose; Humans; Male; Oxcarbazepine; Risperidone | 2003 |
Treatment of a rare psychopathological phenomenon: tactile hallucinations and the delusional other.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Chronic Disease; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychomotor Agitation; Risperidone; Schizophrenia; Schizophrenic Psychology | 2004 |
Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Olanzapine; Oxcarbazepine; Risperidone | 2005 |
Sertraline for Klüver-Bucy syndrome in an adolescent.
Topics: Adolescent; Antidepressive Agents; Carbamazepine; Drug Therapy, Combination; Female; Humans; Kluver-Bucy Syndrome; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Mania associated with multiple paraphilias.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Male; Middle Aged; Paraphilic Disorders; Risperidone | 2006 |
Atypical antipsychotics related metabolic syndrome in bipolar patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Carbamazepine; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Triazines; Valproic Acid | 2007 |
Characteristics of psychotic patients with foreign accent syndrome.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; Humans; Language; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Olanzapine; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Valproic Acid; Verbal Behavior | 2007 |
Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
Topics: Adult; Aggression; Antipsychotic Agents; Attitude of Health Personnel; Autistic Disorder; Carbamazepine; Child; Citalopram; Consensus; Humans; Mental Disorders; Risperidone; Self-Injurious Behavior; Surveys and Questionnaires | 2008 |
Deconstructing a medication regimen.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid | 2008 |
Unilateral rubral tremor following treatment with risperidone.
Topics: Anticonvulsants; Antipsychotic Agents; Ataxia; Behavior Therapy; Bipolar Disorder; Brain; Carbamazepine; Clonazepam; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Neural Pathways; Neurologic Examination; Red Nucleus; Risperidone; Valproic Acid; Young Adult | 2009 |
Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Olanzapine; Oxcarbazepine; Piperazines; Prospective Studies; Quinolones; Risperidone; Triazines; Valproic Acid | 2010 |
Antipsychotic prescribing practices following withdrawal of concomitant carbamazepine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Carbamazepine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Female; Humans; Male; Medical Audit; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk Factors; Risperidone | 2009 |
Pharmacokinetic drug-drug interactions between olanzapine and valproate need to be better studied.
Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Metabolic Clearance Rate; Olanzapine; Risperidone; Valproic Acid | 2010 |
Anticonvulsant hypersensitivity syndrome: a rare and serious complication.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Eruptions; Female; Hepatomegaly; Humans; Lithium Compounds; Lymphatic Diseases; Pruritus; Risperidone; Serum Albumin; Splenomegaly; Syndrome | 2011 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Differential; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Humans; Lorazepam; Male; Olanzapine; Patient Admission; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Risperidone; Schizophrenia, Catatonic | 2013 |
Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Carbamazepine; Causality; Dibenzothiazepines; Drug-Related Side Effects and Adverse Reactions; Female; Galactorrhea; Humans; Lamotrigine; Logistic Models; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Switzerland; Triazines; Valproic Acid; Weight Gain; Young Adult | 2013 |
Mania after termination of epilepsy treatment: a case report.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Monitoring; Epilepsies, Partial; Female; Humans; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Withholding Treatment | 2013 |
New-onset extrapyramidal symptoms following oxcarbazepine discontinuation in a child receiving risperidone.
Topics: Antipsychotic Agents; Carbamazepine; Child; Drug Interactions; Drug Therapy, Combination; Humans; Male; Movement Disorders; Oxcarbazepine; Risperidone; Substance Withdrawal Syndrome | 2014 |
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage].
Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Mental Disorders; Risperidone | 2015 |
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paliperidone Palmitate; Risperidone; Triazines; Valproic Acid; Young Adult | 2016 |
The Use of Carbamazepine to Expedite Metabolism of Risperidone Long-Acting Injection Through Induction of CYP3A4 in a Patient With Extrapyramidal Symptoms.
Topics: Adult; Basal Ganglia Diseases; Carbamazepine; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Enzyme Induction; Humans; Male; Psychotic Disorders; Risperidone | 2018 |
[Risperidone and carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion: case study].
Topics: Antimanic Agents; Antipsychotic Agents; Carbamazepine; Female; Humans; Inappropriate ADH Syndrome; Middle Aged; Psychotic Disorders; Risperidone | 2019 |
Royal Eschizophilia. Genealogical delusion or Mignon delusion as a pathoplastic realization.
Topics: Age Factors; Antipsychotic Agents; Carbamazepine; Delusions; Disease Progression; Fellowships and Scholarships; Female; Genealogy and Heraldry; Hallucinations; Humans; Middle Aged; Paliperidone Palmitate; Piperazines; Risperidone; Thiazoles; Time Factors | 2019 |
A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Computer Simulation; Drug Discovery; Epirizole; Gene Expression Profiling; Gene Expression Regulation; Humans; Induced Pluripotent Stem Cells; MCF-7 Cells; Mice; Naloxone; Narcotic Antagonists; Neural Stem Cells; Neurodevelopmental Disorders; Neurons; PC-3 Cells; Perphenazine; Primary Cell Culture; Risperidone; RNA-Seq; Single-Cell Analysis; Transcriptome; Trazodone; Trimipramine | 2021 |
Precision psychiatry: The complexity of personalizing antipsychotic dosing.
Topics: Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Female; Humans; Male; Paliperidone Palmitate; Psychiatry; Risperidone | 2022 |
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Japan; Lamotrigine; Lithium Carbonate; Olanzapine; Quetiapine Fumarate; Risperidone | 2022 |
On-farm Occurrence of Pharmaceuticals and Their Environmental Hazard: Case Study of a Tropical Dairy farm.
Topics: Acetaminophen; Animals; Caffeine; Carbamazepine; Environmental Monitoring; Farms; Ibuprofen; Ketoprofen; Pharmaceutical Preparations; Risperidone; Wastewater; Water; Water Pollutants, Chemical | 2023 |